Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

Abstract

Our 27% actual 5-year survival rate for patients with resected PC is superior to that previously reported, and it is influenced by our emphasis on detailed staging and patient selection, a standardized operative approach, and routine use of multimodality therapy.